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Fatigue is a common and disabling symptom in patients with Multiple Sclerosis (PwMS).
Its pathogenesis, however, is still not fully understood. Potential psychological roots, in
particular, have received little attention to date. The present study examined the
association of childhood adversities, specific trait characteristics, and MS disease
characteristics with fatigue symptoms utilizing path analysis. Five hundred and seventy-
one PwMS participated in an online survey. Standardized psychometric tools were
applied. The Childhood Trauma Questionnaire (CTQ) served to assess childhood
adversities. Trait variables were alexithymia (Toronto Alexithymia Scale; TAS-26) and
early maladaptive schemas (Young Schema Questionnaire; YSQ). Current pathology
comprised depression (Beck’s Depression Inventory FastScreen; BDI-FS) and anxiety
symptoms (State-Trait Anxiety Inventory; STAI-state), as well as physical disability (Patient
determined Disease Steps; PDDS). The Fatigue Scale for Motor and Cognitive Functions
(FSMC) was the primary outcome variable measuring fatigue. PwMS displayed high levels
of fatigue and depression (mean FSMC score: 72; mean BDI-II score: 18). The final path
model revealed that CTQ emotional neglect and emotional abuse remained as the only
significant childhood adversity variables associated with fatigue. There were differential
associations for the trait variables and current pathology: TAS-26, the YSQ domain
impaired autonomy and performance, as well as all current pathology measures had direct
effects on fatigue symptoms, accounting for 28.2% of the FSMC variance. Bayesian
estimation also revealed indirect effects from the two CTQ subscales on FSMC. The final
model fitted the data well, also after a cross-validation check and after replacing the FSMC
with the Chalder Fatigue Questionnaire (CFQ). This study suggests an association
psychological factors on fatigue in Multiple Sclerosis. Childhood adversities, as well as
specific trait characteristics, seem to be associated with current pathology and fatigue
symptoms. The article discusses potential implications and limitations.
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Fatigue is among the most disabling symptom in patients with
multiple sclerosis (PwMS) (1). It affects over 75% of all PwMS (2,
3). Moreover, fatigue is the primary factor for MS-related early
retirement (4, 5). Research on the pathogenesis of MS fatigue has
identified several (neuro-) biological, immunological, and
neurophysiological correlates (1). However, the multifactorial
genesis of MS-fatigue remains incompletely understood.
Several studies have suggested that psychological factors
might also contribute to MS fatigue, as, for example, indicated
by its association with depression (6, 7). Moreover, since
behavioral interventions such as Cognitive Behavioral Therapy
(CBT) or mindfulness-based approaches are capable of
effectively reducing fatigue severity in this PwMS (8),
psychological underpinnings appear to modulate aspects of
fatigue too.
However, knowledge about the relative contribution of
psychological factors to MS fatigue and their functional
significance remain limited. Interestingly, evidence from other
chronic disorders such as HIV (9, 10), cancer (11, 12), or chronic
fatigue syndrome [CFS; (13, 14)] suggests a potential link
between fatigue, early life adversities, and traumatic stress. The
present exploratory study aimed to interrelate these factors, and
assess their relative contribution to fatigue severity in a large
sample of PwMS, by conducting an online survey and utilizing a
path-analytic approach.MATERIAL AND METHODS
Participants
Participants were recruited via advertisements on the website of
the German MS Society (Deutsche Multiple Sklerose
Gesellschaft, DMSG) from July 2018 to March 2019. In
addition, flyers and newsletters were used to advertise the
study at a large rehabilitation center (Kliniken Schmieder
Konstanz) and the MS outpatient clinic of the University
Medical Center Hamburg-Eppendorf.
Patients were eligible if they had a self-reported diagnosis of
MS and if they were at least 18 years old. Access to the Internet
was mandatory. Out of a total of 1.490 individuals who registered
via the website, 608 (41%) completed the study. In order to avoid
the imputation of missing data, only complete data sets were
included (n = 571). All participants provided full informed
consent prior to enrolment. The ethical review board of the
University of Konstanz approved the study in June 2018, prior to
enrolment of the first participant. The study was conducted
following the European data protection regulation (EU-GDPR).
Study Procedure
The flyers in the Kliniken Schmieder Konstanz, the University
Medical Center Hamburg-Eppendorf, and the website of the
DMSG provided a link to connect directly to the online survey
(Unipark survey software, Globalpark AG, Hürth). PwMS
provided informed consent online before participation. First,
PwMS completed questions related demographic and clinicalFrontiers in Psychiatry | www.frontiersin.org 2characteristics {sex, age, MS duration, medication, education,
marital status, psychiatric disorders, and the Patient determined
Disease Steps [PDDS; (15)] as a measure of disability}. Second,
they completed a battery of questionnaires (see below). The
duration of the whole survey was approximately 65 min.
Measures
The study utilized two measures of fatigue, the Fatigue Scale for
Motor and Cognitive Functions (FSMC), and the Chalder Fatigue
Questionnaire [CFQ, (16)], using the validated German versions
(17, 18). The German version of the Beck Depression Inventory
[BDI-II, (19)] served to assess current symptoms of depression. A
score of 13 is the cut-off score for as validated for the German
version [see (20)] and has also been validated for use in pwMS
(21, 22). For the inclusion into the path model, the shortened
BDI-II-FastScreen was used [BDI-FS; (23)]. The BDI-FS omits
items covering vegetative and somatic aspects of depression, thus
avoiding confounding of the associations between depression and
fatigue in the model that could be caused by overlapping items on
fatigue and related symptoms. The German version of the
Patient-Determined Disease Steps [PDDS, (15)] served as a
measure of disability. The PDDS is a self-report measure which
strongly correlates with the neurologist-rated Expanded Disability
Status Scale [EDSS, (24)]. To assess alexithymia, the German
version of the Toronto-Alexithymia-Scale-26 [TAS-26, (25, 26)]
was administered. The German version of the Childhood Trauma
Questionnaire [CTQ, (27, 28)] is a self-report questionnaire for
the assessment of adverse childhood experiences. It is valid for the
application in individuals aged 12 years or older. The CTQ has
five subscales that were all considered in the present study: 1. CTQ
emotional abuse; 2. CTQ physical abuse; 3. CTQ sexual abuse; 4.
CTQ emotional neglect; and 5. CTQ physical neglect. For the
assessment of symptoms of anxiety, the present study used the
short form of the German State-Trait Anxiety Inventory [STAI,
(29, 30)], with an emphasis on the current symptoms, assessed
with the State Anxiety Scale (STAI-State). The Young Schema-
Questionnaire – Short Form 3 [YSQ, (31)] is a measure to assess
early maladaptive schemas (EMS), which has been translated and
validated in German (32). Young (33) suggest that schemas form
domains, which represent the hypothesized developmental
origins of the schemas. Each of the domains represents a
grouping of developmental needs. Young postulates five
domains that were also considered in the present study: 1. YSQ
disconnection and rejection; 2. YSQ impaired autonomy and
performance; 3. YSQ impaired limits; 4. YSQ other-directedness;
and 5. YSQ over-vigilance and inhibition. Detailed information on
the scoring of each measure can be found in Supplement 3.
Data Analysis
In a first step, Pearson-correlations between the main variables of
interest included in the path analysis served to display the zero-
order correlations. According to Cohen (34), correlation
coefficients >.10 represent small, >.30 medium, and >.50 large
effects. The supplement contains the respective table
(Supplement 1, 2).
Path analyses calculated in AMOS 25 for Windows served to
model the complex relations between 1) childhood adversities, 2)August 2020 | Volume 11 | Article 811
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fatigue. All other analyses were carried out with SPSS 25 for
Windows. Fatigue, as measured with the FSMC, was the primary
dependent variable. All other variables served as predictor
variables on the respective levels:
The model followed the hypotheses that childhood precedes
the development of a stable personality and that the development
of a stable personality precedes current pathology and fatigue
symptoms. Therefore, 1. CTQ subscales constituted the first level
of the predictor variables, 2. YSQ schema domains and
alexithymia the second level, and 3. the current depression and
anxiety symptoms, as well as the subjectively reported disability,
the third level. Statistical modeling started with the full model
and a backward exclusion approach, excluding non-significant
paths stepwise. During this procedure, one step also acknowledged
the content of the relationship between variables where the
identification of a non-significant path was equivocal due to a
significant variance overlap between path-coefficients from two
CTQ subscales. The fit indices CFI (comparative fit index) and
RMSEA (root mean square error of approximation) according to
the cut-off scores defined in Hu & Bentler (35) served to estimate
the fit of the final model.
First, maximum likelihood estimation was applied. However,
multivariate kurtosis and skewness values indicated deviations
from multivariate normality [kurtosis = 10.16; c.r. = 7.18; (34)],
in particular, due to skewed CTQ distributions. These deviations
are critical as violations of multivariate normality may cause an
inflation of Chi-Square values (35). The Bollen-Stine bootstrap p
confirmed that the path model based on Maximum Likelihood
estimation did not fit the data adequately (p = .021). Therefore,
the repeated statistical modeling utilized the backward procedure
with a bootstrapping approach. Bootstrapping, with 50.000
bootstrap samples, served to calculate bias-corrected
confidence intervals for the path coefficients. Path coefficients
that lay within the confidence interval ranging from (SM -
1,96*SE) to (SM + 1,96*SE) were considered as statistically not
significant. In the final model, four cases displayed Mahalanobis
distances at p <.001 fulfilling the criterion of outliers (36).
However, the exclusion of these outliers did not have a
significant impact on the final model. Thus, maintaining these
data in the data set was justified.
Additionally, to support the validity of the final selected
model, the model fit was re-estimated by using the second
fatigue measure (CFQ) as the dependent variable. Furthermore,
a cross-validation approach helped to estimate the robustness of
the proposed model by randomly splitting the sample into two
halves. Model fits were re-estimated for the split sub-samples.
Finally, Bayesian estimation served to calculate the indirect
effects of childhood adversities on fatigue symptoms. The
Markov Chain Monte Carlo (MCMC) method implemented in
AMOS was chosen. This Monte Carlo technique utilizes a
random number generator to draw samples, serving to
estimate the posterior distribution of parameters in the model.
Ninety-five percent confidence intervals were chosen to
determine statistical significance. The level of significance was
alpha <.05.Frontiers in Psychiatry | www.frontiersin.org 3RESULTS
Sample Characteristics Table 1 provides an overview of the
sample characteristics. Means (SD) represent the primary
estimates unless otherwise specified.
The sample had a distribution of clinical characteristics
reasonably typical for an MS outpatient sample with a female
to male ratio of 3.3 to 1 and approximately 70% RRMS patients.
However, depression scores were higher than what is typical for
this population (65.5% above the clinical cut-off of ≥13 on the
BDI-II for at least mild depressive symptoms).
Path Model
Before inclusion in the path model, inter-correlations between
the primary outcome variables were calculated. Supplement 1
displays Pearson correlation coefficients between the fatigue
measures and the measures assessing symptom severity.
Supplement 2 contains Pearson correlations between current
symptom severity, fatigue, and childhood adversities, as well as
schema domains (EMS) and alexithymia.
In contrast to a multiple linear regression analyses that
primarily focuses on the relationship between one dependent
variable and various predictor variables, a path model has the
advantage of combining different simple regression models into
one overarching model. Figure 1 displays the final path model
after stepwise removal of non-significant paths in order to
improve model fit. By removing non-significant paths from the
initial model, only those paths that are meaningful in terms of
the prediction of one variable from other variables remain in the
final model.TABLE 1 | Sample characteristics.
Total (N = 571)
age in years (M/SD) 43.4 (10.9)
sex (females/males) 438/133
education
no graduation 2 (.4%)
9 years 39 (6.8%)
10 years 173 (30.3%)
13 years 357 (62.5%)
disease duration in years (M/SD) 9.1 (7.6)
PDDS (M/SD) 2.4 (1.9)
Disease course N (%)
Clinically isolated syndrome 7 (1.2%)
Relapsing-remitting (RRMS) 392 (68.7%)
Secondary progressive (SPMS) 75 (13.1%)
Primary progressive (PPMS) 52 (9.1%)
Unknown 45 (7.9%)
FSMC (M/SD) 72.26 (16.16)
CFQ (M/SD) 21.06 (6.08)
BDI-II (M/SD) 17.71 (10.39)
BDI-FS (M/SD) 4.41 (3.63)
Clinically relevant depressive symptoms (BDI-II 13 or
higher) N, %
374 (65.5)August 2020 | VolumeN, number of participants; SD, Standard Deviation; M, mean; CFQ, Chalder Fatigue
Questionnaire; FSMC, Fatigue Scale for Motor and Cognitive Functions; BDI-FS, Beck
Depression Inventory II FastScreen; BDI-II, Beck Depression Inventory II; PDDS, Patient
Determined Disease Steps.11 | Article 811
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p = .016, Chi2/df = 1.80, CFI = 1.00, RMSEA = .04]. To facilitate the
presentation of the complex relations between the variables, Figure 1
only displays the relevant paths without the beta coefficient values.
The subsequent figures focus on specific relationships. They also
display the bootstrapped 95% confidence intervals.
Figure 2 displays the relation between childhood adversities
and trait measures, i.e., the first two levels of the path model.
From the five different CTQ scales initially included in the full
model, only emotional neglect and emotional abuse remained as
significant predictors in the final model. For a better visual
representation, Figure 2 displays the path coefficient from the
predictor variables CTQ emotional abuse and CTQ emotional
neglect on the PwMSs’ trait characteristics, indicated by their
EMSs (YSQ) and their level of alexithymia (TAS-26) separately.
The results highlight the importance of emotional disturbances
in childhood and adolescence. Both CTQ scales significantly
predict four of the five YSQ scales (1. YSQ disconnection and
rejection; 2. YSQ impaired autonomy and performance; 3. YSQ
other-directedness; and 4. YSQ over-vigilance and inhibition)
that all remained in the final model. Also, CTQ emotional neglect
predicted alexithymia, and the YSQ subscale impaired limits.
For the relation between the trait variables and current
symptom severity (Figure 3), alexithymia (TAS-26) and the
YSQ scales impaired autonomy and performance, disconnection
and rejection, as well as over-vigilance and inhibition, predictedFrontiers in Psychiatry | www.frontiersin.org 4depression symptoms. Higher alexithymia scores, as well as higher
perceived disconnection and rejection, higher impairments in
autonomy and performance, and higher other-directedness
predicted more severe anxiety symptoms. PwMS who reported
higher levels of disconnection and rejection, as well as impaired
limits, also scored higher on the PDDS scale. As indicated by the
negative path coefficients, PwMS with lower other-directedness
and less over-vigilance and inhibition reported higher disability
(PDDS). These results indicate that specific trait characteristics,
which in turn are predicted by early life adversities, do have not
only a significant impact on the current anxiety and depression
severity but are also associated with self-reported disability.
Figure 4 displays all direct significant predictor variables for the
prediction of current fatigue severity. Current anxiety and depressive
symptom severity directly influence fatigue severity. More severe
symptoms of anxiety and depression are associated with higher
fatigue scores. PwMS with higher disability also reported more
severe fatigue symptoms. As indicated by the direct path from the
TAS-26, PwMS with higher scores in alexithymia tend to experience
higher fatigue severity. Additionally, PwMS who report impaired
autonomy and performance on the respective YSQ-sub-scale also
tend to report more fatigue symptoms. Thus, the trait variables
TAS-26 and YSQ impaired autonomy and performance, also have a
direct impact on fatigue symptoms. Additionally, there were small
but significant indirect effects of reported emotional abuse (M =
.05, SE <.01) and emotional neglect (M = .11, SE <.01) on fatigue.FIGURE 1 | Final path model with all statistically significant paths between the four levels of early adversities, trait variables, current pathology, and fatigue
symptoms. CTQ, Childhood Trauma Questionnaire; TAS-26, Toronto Alexithymia Scale 26; YSQ, Young Schema Questionnaire S3; STAI-State, State Trait Anxiety
Inventory-State Scale; BDI-FS, Beck Depression Inventory II FastScreen; PDDS, Patient Determined Disease Steps; FSMC, Fatigue Scale for Motor and Cognitive
Functions. Only statistically significant paths are printed.August 2020 | Volume 11 | Article 811
Pust et al. Childhood Adversity and MS FatigueThus, adverse emotional experiences during childhood also
indirectly influence current fatigue symptoms. The path model
accounted for 28.2% of the fatigue severity variance.
Validation of the Path Model With a
Second Fatigue Measure
The model fit remained excellent after re-calculating the final
model with the CFQ instead of the FSMC as a measure for
fatigue [Chi2 (20) = 34.25, p = .024, Chi2/df = 1.71, CFI = 1.00,
RMSEA = .04]. This result supports the validity of the obtained
model, as it was possible to replicate it with another
fatigue measure.
Cross-Validation Check
As another approach to support the validity of the model, it was
re-calculated after splitting the sample into two equally large
halves. This method serves to test whether the fit measures
remain stable, when a different composition of the sample is
chosen, or whether the fit measures are susceptible to one
particular selection of participants and not replicable. As for
the previous calculations, data fit the hypothesized model in both
subsamples [split half 1 (n = 285): Chi2 (20) = 21.86, p = .348,
Chi2/df = 1.09, CFI = 1.00, RMSEA = .02; split half 2 (n = 286):
Chi2 (20) = 32.78, p = .036, Chi2/df = 1.64, CFI = .99, RMSEA =
.05]. Similar results were observed after replacing the FSMC with
the CFQ [split half 1 (n = 285): Chi2 (20) = 21.84, p = .349, Chi2/
df = 1.09, CFI = 1.00, RMSEA = .02; split half 2 (n = 286): Chi2Frontiers in Psychiatry | www.frontiersin.org 5(20) = 30.06, p = .069, Chi2/df = 1.50, CFI = .99, RMSEA = .04].
Thus, the obtained results support the validity of the final
model obtained.DISCUSSION
The present study aimed to investigate the association of
different psychological factors with current fatigue symptoms
in MS. In particular, it focused on 1) childhood adversities as
measures of early adverse experiences, 2) Alexithymia and EMS
according to the Schema-therapeutic model as measures of trait
characteristics, 3) anxiety, depression symptoms, as well as
disability, and 4) fatigue as the primary outcome variable. Path
analysis served to model the complex relations and the relative
contributions of these variables to fatigue severity.
Among the five CTQ childhood adversities subscales, only the
subscales assessing emotional neglect and abuse remained in the
final model, while all other subscales made no significant
contribution (physical abuse, sexual abuse, and physical
neglect). This finding corroborates and extends a previous
cohort study (37), where emotional abuse and emotional
neglect showed the largest effect sizes among the different types
of childhood trauma in MS compared to healthy controls.
Together, this adds to a growing literature from cross-sectional
(37, 38) and register-based studies (39) that have indicated a link
between childhood adversity, trauma-related disorders, andFIGURE 2 | Path coefficients from the predictor variables CTQ emotional neglect (left) and CTQ emotional abuse (right) on the YSQ sub scales and the TAS 26
alexithymia scales. The figure displays the levels of early adversities and trait variables taken from the final path model displayed in Figure 1. CTQ, Childhood Trauma
Questionnaire; TAS-26, Toronto Alexithymia Scale 26; YSQ, Young Schema Questionnaire S3. For a better visual presentation, the paths from the CTQ subscales
CTQ emotional neglect (left) and CTQ emotional abuse (right) on the trait variables are printed separately, with paths belonging to the other predictor variable
respectively being greyed out. Standardized beta coefficients are displayed.August 2020 | Volume 11 | Article 811
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specificity of emotional vs. physical domains of abuse, the
potential causes for this remain unknown. Some of this might
be due to statistical power as emotional abuse tends to have a
higher reported frequency in MS [e.g. (37)]. It is tempting to
speculate that other factors, including possible differential
biological substrates of different forms of abuse, could also play
a role here and this should be investigated in future research.
Further studies should focus on the comparison between
PwMS, patients with other somatic disorders and co-morbid
fatigue, as well as healthy controls. This would help to
disentangle the specificity of the link between adverse
emotional experiences and fatigue as an MS-related or a more
general phenomenon. A link between adverse emotional
experiences and fatigue has also been reported in other
medical conditions, such as CFS or cancer (40, 41).
It should be noted that these findings could at least in part be
due to an overlap with comorbid or misdiagnosed depression
(14). In the present study, we used the BDI-II-FastScreen to
overcome the shortcoming of a symptom overlap (i.e. somatic/
vegetative symptoms of depression that may also be impact
responses on fatigue questionnaires). Still, the differentiation
between the different phenomena requires further study.
While our study was a cross-sectional survey, the assessment
of emotional neglect and emotional abuse using the CTQ is a
retrospective assessment of experiences during childhood andFrontiers in Psychiatry | www.frontiersin.org 6adolescence. Thus, these experiences will in most or all cases be
before MS onset (which only rarely manifests before the age of 18
and typically has an age of onset between 20 and 30 years of age).
There are several possibilities that may explain the increased
frequencies of adverse childhood experiences reported by MS
patients compared to healthy controls in previous studies (37).
For example, it is conceivable that MS patients are more likely to
recall or report such experiences (a phenomenon known as
“effort after meaning”). However, the large population-based
by Song et al. (39) used documented diagnoses of stress-related
disorders (including PTSD) preceding the MS diagnosis by
several years and thus cannot be explained by “effort after
meaning”. This may suggest that direct or indirect effects of
childhood adversity may increase the risk of subsequently
developing MS (or other autoimmune diseases). Currently
these mechanisms remain unknown but they may include
behavioral factors [e.g. altered health behaviors such as diet,
exercise, or smoking, the latter of which is a known risk factor for
MS, see (42)]. Moreover, there might be biological pathways (e.g.
altered stress response system regulation or inflammatory
mechanisms) that have been linked to childhood trauma (43)
and might also play a role in MS (44). Similarly, these
mechanisms could also contribute to MS symptoms such as
fatigue. However, at this point, this remains speculative and
detailed studies, ideally longitudinal in nature, are required to
probe this hypothesis and explore potential behavioral orFIGURE 3 | Path coefficients from the YSQ and TAS-26 trait variables on the variables assessing current symptom severity. The figure displays the levels of trait
variables and symptom severity taken from the final path model displayed in Figure 1. YSQ, Young Schema Questionnaire S3; TAS-26, Toronto Alexithymia Scale
26; STAI-State, State Trait Anxiety Inventory State Scale; BDI-FS, Beck Depression Inventory II FastScreen; PDDS, Patient Determined Disease Steps. For a better
visual presentation, the paths from the trait variables on the variables measuring current symptom severity STAI-State and PDDS (left), as well as the BDI-FS (right)
are printed separately, with paths belonging to the other predictor variable respectively being greyed out. Standardized beta coefficients are displayed.August 2020 | Volume 11 | Article 811
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between childhood adversity and MS risk or symptom severity.
Based on the present analysis, the reported childhood
adversities may not only be more common in MS than the
general population but could indirectly contribute to symptom
severity, particularly concerning depression and fatigue. The
presented model suggests that these associations could be
mediated via Early Maladaptive Schemas as measured by
the YSQ.
These results are in line with studies in which early adversities
predicted the development of EMS in particular in affective
disorders (45) and individuals with personality disorders (46).
Similarly, research on different psychopathologies, such as
affective disorders (47), personality disorders (48), or adult
dissociation (49), has reported a relation between emotional
abuse/neglect and the development of alexithymia as a trait
characteristic. The MS literature also consistently describes
moderate associations between symptoms of anxiety,
depression as well as disability, and fatigue (50, 51), which the
proposed path model from our study confirms. Intriguingly, trait
characteristics predicted current self-reported disability, which
may reflect an overlap between psychological and somatic
phenomena. However, while the associations were statistically
significant in this large cohort, the magnitude of the contribution
of YSQ and alexithymia to fatigue scores was rather small and a
sizeable portion of variability in fatigue severity remainedFrontiers in Psychiatry | www.frontiersin.org 7unexplained, suggesting that other factors not included in our
model likely contribute to MS-associated fatigue.
Considering the relation between adverse childhood
experiences and MS-related fatigue indicated by our data, it is
tempting to hypothesize that Schema Therapy could provide a
useful taxonomy to understand and link the functional aspect of
fatigue to childhood adversities. Schema Therapy provides a
trans-diagnostic conceptual and empirically validated framework
(32, 51). A central aspect of schema therapy is the concept of
EMS, thought to develop in childhood (52). While this might be
interesting from a conceptual point of view, the cross-sectional
associations between schemas and fatigue alone are not sufficient
to claim causality, and no clinical trial to date has explored the
potential of schema therapy for neuropsychiatric aspects of MS
(including fatigue).
However, further research is required in order to elaborate a
profound etiologcal working model on how early life adversities
could manifest in MS and contribute to associated symptoms
such as fatigue or psychopathology. While Young’s Schema
Questionnaire assesses EMS, it does not capture the functional
or dysfunctional nature of these concepts. Measures, such as the
OPD conflict questionnaire (53) or the Schema Mode Inventory
(54) could deepen our understanding of the psychosomatic or
psychodynamic nature of fatigue. Fatigue could for example
constitute a potential defense mechanism according to
psychodynamic theories. Moreover, interactions on both theFIGURE 4 | Path coefficients from all variables with direct effect on fatigue symptoms as the primary outcome variable PDDS. CTQ, Childhood Trauma
Questionnaire; TAS-26, Toronto Alexithymia Scale 26; YSQ, Young Schema Questionnaire S3; STAI-State, State Trait Anxiety Inventory State Scale; BDI-FS, Beck
Depression Inventory II FastScreen; PDDS, Patient Determined Disease Steps; FSMC, Fatigue Scale for Motor and Cognitive Functions. For a better visual
presentation, only significant direct paths from the various predictor variables on the FSMC primary outcome variable are printed in black. Standardized beta
coefficients are displayed.August 2020 | Volume 11 | Article 811
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specific relation between adverse emotional experience and
MS-fatigue found in this study and should be targeted by
future research strategies.
The major limitation of the present study is that all data were
obtained cross-sectionally and are correlational and the path
model’s hierarchical structure does not necessarily imply a cause-
effect relationship between the three levels. Moreover, responses
in the CTQ specifically may be prone to recall bias or effort-after-
meaning effects.
The present study was web-based and all MS diagnoses and
clinical data rely on participants’ self-reports A selection bias for
the PwMS sample can also not be excluded. The advertisement of
the study as a survey on fatigue in MS may explain the high
average levels of fatigue in our sample. In a related matter,
depression scores were quite high, and the percentage of
patients who had depressive symptoms above the clinical cut-
off was higher than what is common in MS (55). Structured
clinical interviews would have been helpful to validate anxiety
and depression symptoms. Bed-ridden patients or patients who
do not have access to the internet might also not have
participated. Biased sample characteristics could limit the
generalizability of the present findings.
Moreover, MS has a genetic component and can cluster in
families (56). Although the majority of MS patients do not have
first-degree relatives with the disease, it is conceivable that
genetic or environmental factors linked to family history of MS
can affect childhood experiences. In our study, we did not assess
and thus could not explore the effect of parental MS on any of the
measures obtained.
Taken together, the present study revealed a path model based
on a large sample of PwMS from an online-survey. Among
different childhood adversities, only emotional neglect and
emotional abuse predicted certain personality traits, current
disability, and psychopathology, as well as MS fatigue
symptoms. Alexithymia, as well as EMS, play a mediating role
in the relation between childhood emotional abuse/neglect and
current disability, as well as symptoms of depression and anxiety.
Current disability and symptoms of depression and anxiety were,
in turn, associated with fatigue symptoms. Thus, the current study
not only confirms the well-established relation between
psychopathology and fatigue in MS but is -to the best of our
knowledge- the first to also establish a link to early adversities and
specific trait characteristics. If early abuse and neglect increase the
probability for the development of individual personalityFrontiers in Psychiatry | www.frontiersin.org 8predispositions and the susceptibility to develop fatigue, this
might provide a new perspective on the genesis of MS-fatigue.DATA AVAILABILITY STATEMENT
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